Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 818, Issue -, Pages 115-123Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2017.10.033
Keywords
Puerarin; mu-opioid receptor; Skeletal muscle; Insulin resistance; Diabetes
Categories
Funding
- Natural Science Foundation of Zhejiang Province of China [LY13H290007]
- Wenzhou Public Welfare Science and Technology Project [Y20170167]
- National Natural Science Foundation of China [81570775]
- National High Technology Research and Development Program (863 Program) of China [2010CB945103]
Ask authors/readers for more resources
Puerarin, a major active isoflavone extracted from the root of Pueraria lobate, significantly increases plasma beta-endorphin and insulin levels and improves impaired insulin signaling in diabetic animals. However, the target tissues and underlying mechanisms in and through which puerarin functions to ameliorating insulin resistance remains largely unclear. In this study, we showed that puerarin enhanced mu-opioid receptor expression and phosphorylation, and increased insulin-stimulated glucose transporter 4 translocation to the plasma membrane in the skeletal muscle of diabetic rats, which were recaptured by a direct application of puerarin in the palmitate-induced insulin-resistant L6 myotubes. Naloxone, an antagonist of mu-opioid receptor, blocked these functions of puerarin. No beta-endorphin was detected either in the muscle of diabetic rats or in the palmitate-induced insulin-resistant L6 cells. Furthermore, we presented the evidence to show the interaction between mu-opioid receptor and insulin receptor substrate 1 in the muscle tissues and cells. These results suggested that puerarin improved insulin sensitivity in the skeletal muscle at least in part by its local effects involving mu-opioid receptor function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available